Abstract:Oxidative stress in the hypothalamic paraventricular nucleus (PVN) contributes greatly to the development of hypertension. The recombinant nuclear respiratory factor 1 ( Nrf1 ) regulates the transcription of several genes related to mitochondrial respiratory chain function or antioxidant expression, and thus may be involved in the pathogenesis of hypertension. Here we show that in the two-kidney, one-clip (2K1C) hypertensive rats the transcription level of Nrf1 was elevated comparing to the normotensive controls. Knocking down of Nrf1 in the PVN of 2K1C rats can significantly reduce their blood pressure and level of plasma norepinephrine (NE). Analysis revealed significant reduction of superoxide production level in both whole cell and mitochondria, along with up-regulation of superoxide dismutase 1 (Cu/Zn-SOD), NAD(P)H: quinone oxidoreductase 1 ( NQO1 ), thioredoxin-dependent peroxiredoxin 3 ( Prdx3 ), cytochrome c ( Cyt-c ) and glutathione synthesis rate-limiting enzyme (glutamyl-cysteine ligase catalytic subunit ( Gclc ) and modifier subunit ( Gclm )), and down-regulation of cytochrome c oxidase subunit VI c ( Cox6c ) transcription after Nrf1 knock-down. In addition, the reduced ATP production and elevated mitochondrial membrane potential in the PVN of 2K1C rats were reinstated with Nrf1 knock-down, together with restored expression of peroxisome proliferator-activated receptor-γ coactivator 1α ( PGC-1α ), mitochondrial transcription factor A ( Tfam ), coiled-coil myosin-like BCL2-interacting protein ( Beclin1 ), and Mitofusin 1 ( Mfn1 ), which are related to the mitochondrial biogenesis, fusion, and autophagy. Together, the results indicate that the PVN Nrf1 is associated with the development of 2K1C-induced hypertension, and Nrf1 knock-down in the PVN can alleviate hypertension through intervention of mitochondrial function and restorement of the production-removal balance of superoxide.

Reactive oxygen/nitrogen species scavenging multi-enzyme mimetic ultrasmall calcium hexacyanoferrate (III) nanozyme for hypertension remedy

Reactive Oxygen Species-Responsive Nanotherapy for the Prevention and Treatment of Cerebral Ischemia–reperfusion Injury

Ultrathin Niobium Carbide MXenzyme for Remedying Hypertension by Antioxidative and Neuroprotective Actions.

Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration

Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases

Multi-enzymatic Activities of Ultrasmall Ruthenium Oxide for Anti-Inflammation and Neuroprotection

Nrf1 Knock-Down in the Hypothalamic Paraventricular Nucleus Alleviates Hypertension Through Intervention of Superoxide Production-Removal Balance and Mitochondrial Function

Inhibition of USP1 ameliorates hypertensive nephropathy through regulating oxidative stress and ferroptosis: A precise treatment via SJB3-019A nanodelivery

Engineering Antioxidative Cascade Metal-Phenolic Nanozymes for Alleviating Oxidative Stress During Extracorporeal Blood Purification

A Mn 3 O 4 -Based Antioxidant Nanoplatform Loaded with Tacrolimus to Ameliorate Chronic Kidney Disease by Reducing Inflammation and Oxidative Stress

Bioactive Nanoenzyme Reverses Oxidative Damage and Endoplasmic Reticulum Stress in Neurons under Ischemic Stroke

Au-modified ceria nanozyme prevents and treats hypoxia-induced pulmonary hypertension with greatly improved enzymatic activity and safety

Engineering Ultrasmall Ferroptosis-Targeting and Reactive Oxygen/Nitrogen Species-Scavenging Nanozyme for Alleviating Acute Kidney Injury

Nanozymes Regulate Redox Homeostasis in ROS-Related Inflammation

Reactive Oxygen Species Scavenging Nanomedicine for The Treatment of Ischemic Heart Disease

CeO2/Bovine Serum Albumin Nanoclusters with Robust Reactive Oxygen Species Scavenging and Improved Endothelial Dysfunction Abilities for the Treatment of Pulmonary Hypertension

Metal‐Phenolic Networks Nanoplatform to Mimic Antioxidant Defense System for Broad‐Spectrum Radical Eliminating and Endotoxemia Treatment

A Co-Doped Fe3O4 Nanozyme Shows Enhanced Reactive Oxygen and Nitrogen Species Scavenging Activity and Ameliorates the Deleterious Effects of Ischemic Stroke.

ROS-responsive & scavenging NO nanomedicine for vascular diseases treatment by inhibiting endoplasmic reticulum stress and improving NO bioavailability

Valence Engineering Driven Multiple Mechanisms of Superior Antioxidant Nanosheets for Treatment of Pulmonary Fibrosis

ROS scavenging Mn3O4 nanozymes for in vivo anti-inflammation.